Status:
UNKNOWN
Percutaneous Treatment of Iatrogenic False Femoral Aneurysms by Ultrasound-guided Thrombin Injection
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Femoral; Aneurysm
Eligibility:
All Genders
18+ years
Brief Summary
Since the 2000s, endovascular procedures have been expanding rapidly in multiple disciplines: cardiology, radiology, interventional neuroradiology, and of course vascular surgery. Most procedures are ...
Eligibility Criteria
Inclusion
- Patient whose age ≥ 18 years
- Patient with iatrogenic false femoral arterial aneurysm, post arterial or venous puncture, following management for a diagnostic or therapeutic examination.
- Circulating false aneurysm confirmed by an imaging examination (echo-Doppler, angioscanner; angio-MRI).
- Indication for exclusion of false aneurysm
- False aneurysm treated at GHPSJ between 01/09/2020 and 31/12/2022 by thrombin injection
Exclusion
- Patient under guardianship or curatorship
- Patient under court protection
- Patient objecting to the use of his/her data for this research
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05233670
Start Date
December 1 2020
End Date
December 31 2023
Last Update
April 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014